Jake joined NEA in 2006 as a Partner. He focuses on later-stage specialty pharmaceuticals, biotechnology and medical device investments. Jake is actively involved with a number of NEA portfolio companies including Transcept Pharmaceuticals. Prior to joining NEA, Jake worked at MPM Capital as a Partner with the MPM BioEquities Fund, where he specialized in public, PIPE and mezzanine-stage life sciences investing. Previously, he was a healthcare research analyst and portfolio manager at Franklin Templeton Investments. Jake was also an investment banker with Alex. Brown Sons. He received an MBA from the Stanford Graduate School of Business and an AB in Economics from Dartmouth College. Jake holds the Chartered Financial Analyst designation, and is a member of the CFA Society of San Francisco. [ - ]

Jake joined NEA in 2006 as a Partner. He focuses on later-stage specialty pharmaceuticals,... [ + ]